Resurgent Financial Advisors LLC Moderna, Inc. Transaction History

Resurgent Financial Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $192 - $253	-2 Reduced 0.97%	204 $21,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $5,569 - $7,544	-47 Reduced 18.58%	206 $25,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $22,519 - $32,705	-166 Reduced 39.62%	253 $38,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $49,601 - $88,006	419 New	419 $75,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resurgent Financial Advisors LLC with notifications on news.